Presentation
14 March 2018 Clinical trial results using fluorescently labeled antibodies (Conference Presentation)
Eben L. Rosenthal M.D., Nynke van den Berg, Tarn Teraphongphom, Jason Warram
Author Affiliations +
Abstract
Over the past two decades, synergistic innovations in imaging technology have resulted in a revolution in which a range of biomedical applications are now benefiting from fluorescence imaging. Fluorescence imaging of lymph nodes after systemic cetuximab-IRDye800CW administration demonstrated high sensitivity and was capable of identifying additional positive nodes on deep sectioning.
Conference Presentation
© (2018) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Eben L. Rosenthal M.D., Nynke van den Berg, Tarn Teraphongphom, and Jason Warram "Clinical trial results using fluorescently labeled antibodies (Conference Presentation)", Proc. SPIE 10469, Optical Imaging, Therapeutics, and Advanced Technology in Head and Neck Surgery and Otolaryngology 2018, 104690E (14 March 2018); https://doi.org/10.1117/12.2297305
Advertisement
Advertisement
KEYWORDS
Clinical trials

Luminescence

Biomedical optics

Imaging systems

Imaging technologies

Lymphatic system

Back to Top